Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) – Stock analysts at Cantor Fitzgerald raised their FY2026 EPS estimates for shares of Corvus Pharmaceuticals in a research note issued to investors on Wednesday, November 5th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will earn ($0.59) per share for the year, up from their […]

Kura Oncology, Inc. (NASDAQ:KURA – Free Report) – Research analysts at Cantor Fitzgerald dropped their FY2025 EPS estimates for Kura Oncology in a research note issued to investors on Wednesday, November 5th. Cantor Fitzgerald analyst L. Watsek now anticipates that the company will post earnings of ($2.56) per share for the year, down from their […]